Page last updated: 2024-08-22

platinum and Cancer Syndromes, Hereditary

platinum has been researched along with Cancer Syndromes, Hereditary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bartoletti, M; Canzonieri, V; Clemente, N; Corsetti, S; Fornasarig, M; Giorda, G; Lucia, E; Nicoloso, MS; Palazzari, E; Pivetta, T; Puglisi, F; Scalone, S; Segatto, E; Sorio, R; Viel, A; Zdjelar, A	1

Other Studies

1 other study(ies) available for platinum and Cancer Syndromes, Hereditary

Article	Year
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer. Current oncology (Toronto, Ont.), 2022, 07-22, Volume: 29, Issue:8 Topics: Antibodies, Monoclonal, Humanized; Brain Neoplasms; Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplastic Syndromes, Hereditary; Platinum; Programmed Cell Death 1 Receptor	2022

Article

Year

An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.

Current oncology (Toronto, Ont.), 2022, 07-22, Volume: 29, Issue:8

Topics: Antibodies, Monoclonal, Humanized; Brain Neoplasms; Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplastic Syndromes, Hereditary; Platinum; Programmed Cell Death 1 Receptor

2022